PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Stupp, Roger ^{[1
,2
]}

Idbaih, Ahmed ^{[3
]}

Steinberg, David M. ^{[4
]}

Read, William ^{[5
]}

Toms, Steven ^{[6
]}

Barnett, Gene ^{[7
]}

Nicholas, Garth ^{[8
]}

Kim, Chae-Yong ^{[9
]}

Fink, Karen ^{[10
]}

Salmaggi, Andrea ^{[11
]}

Lieberman, Frank ^{[12
]}

Zhu, Jay ^{[13
]}

Taylor, Lynne ^{[14
]}

Stragliotto, Giuseppe ^{[15
]}

Hottinger, Andreas ^{[16
]}

Kirson, Eilon D. ^{[17
]}

Weinberg, Uri

Palti, Yoram ^{[17
]}

Hegi, Monika E. ^{[16
]}

Ram, Zvi ^{[18
]}

机构：

[1] Univ Hosp Zurich, Zurich, Switzerland

[2] Univ Zurich, Zurich, Switzerland

[3] Grp Hosp Pitie Salpetriere, Paris, France

[4] Tel Aviv Univ, Tel Aviv, Israel

[5] Emory Univ Hosp Midtown, Atlanta, GA USA

[6] Geisinger Med Ctr, Danville, PA 17822 USA

[7] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[8] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[9] Seoul Natl Univ Bundang, Seoul, South Korea

[10] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA

[11] Ist Natl Neurol Carlo Besta, Milan, Italy

[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[13] Mem Hermann Hosp, Houston, TX USA

[14] Tufts Med Ctr, Boston, MA USA

[15] Karolinska Hosp, Stockholm, Sweden

[16] CHU Vaudois, Lausanne, Switzerland

[17] Novocure Ltd, Haifa, Israel

[18] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LTBK-01

引用

页码：1 / 1

页数：1

共 50 条

[11] Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
Chen, Chunjui
Xu, Hao
Song, Kun
Zhang, Yi
Zhang, Junyan
Wang, Yang
Sheng, Xiaofang
Chen, Lingchao
Qin, Zhiyong
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[12] Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma
Goldlust, Samuel A.
Singer, Samuel
Cappello, Lori A.
AlMekkawi, Ahmad K.
Lee, Kangmin D.
Ingenito, Anthony C.
Lewis, Brett E.
Nyirenda, Themba
Azmi, Hooman
Kaptain, George J.
NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
[13] A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMA
Sumrall, Ashley
Haggstrom, Daniel
Burri, Stuart
Symanowski, James
NEURO-ONCOLOGY, 2017, 19 : 16 - 16
[14] TUMOR TREATING FIELDS COMBINE WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS OF CHINESE PATIENTS
Qin, Zhiyong
Chen, Lingchao
Chen, Junrui
Yao, Yu
Wu, Jinsong
Zhuang, Dongxiao
Nie, Jigntao
NEURO-ONCOLOGY, 2022, 24 : 82 - 82
[15] SPARE TRIAL: SCALP-SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Miller, Ryan
Song, Andrew
Ali, Ayesha S.
Bar-Ad, Voichita
Martinez, L.
Glass, Jon
Alnahhas, Iyad
Andrews, David
Judy, Kevin
Evans, James
Farrell, Christopher
Werner-Wasik, Maria
Chervoneva, Inna
Ly, May
Palmer, Joshua
Liu, Haisong
Shi, Wenyin
NEURO-ONCOLOGY, 2021, 23 : 43 - 44
[16] Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial
Stupp, Roger
Hegi, Monika E.
Idbaih, Ahmed
Steinberg, David M.
Lhermitte, Benoit
Read, William
Toms, Steven A.
Barnett, Gene H.
Nicholas, Garth
Kim, Chae-Yong
Fink, Karen
Salmaggi, Andrea
Lieberman, Frank S.
Zhu, Jay-Jiguang
Taylor, Lynne
Stragliotto, Giuseppe
Hottinger, Andreas F.
Kirson, Eilon D.
Weinberg, Uri
Palti, Yoram
Ram, Zvi
CANCER RESEARCH, 2017, 77
[17] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
Grossman, Rachel
Limon, Dror
Bokstein, Felix
Ben Harosh, Carmit
Ram, Zvi
CANCER RESEARCH, 2019, 79 (13)
[18] SPARE Trial: Scalp Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (200 kHz) for Patients With Newly Diagnosed Glioblastoma
Miller, R. C.
Song, A. J.
Ali, A.
Bar-Ad, V.
Martinez, N.
Glass, J.
Alnahhas, I.
Andrews, D. W.
Judy, K.
Evans, J.
Farrell, C.
Werner-Wasik, M.
Chervoneva, I.
Ly, M.
Palmer, J. D.
Liu, H.
Shi, W.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E594 - E595
[19] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
Lazaros Lazaridis
Niklas Schäfer
Sarah Teuber-Hanselmann
Tobias Blau
Teresa Schmidt
Christoph Oster
Johannes Weller
Theophilos Tzaridis
Daniela Pierscianek
Kathy Keyvani
Christoph Kleinschnitz
Martin Stuschke
Björn Scheffler
Cornelius Deuschl
Ulrich Sure
Ulrich Herrlinger
Sied Kebir
Martin Glas
Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
[20] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
Lazaridis, Lazaros
Schaefer, Niklas
Teuber-Hanselmann, Sarah
Blau, Tobias
Schmidt, Teresa
Oster, Christoph
Weller, Johannes
Tzaridis, Theophilos
Pierscianek, Daniela
Keyvani, Kathy
Kleinschnitz, Christoph
Stuschke, Martin
Scheffler, Bjoern
Deuschl, Cornelius
Sure, Ulrich
Herrlinger, Ulrich
Kebir, Sied
Glas, Martin
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792

← 1 2 3 4 5 →